These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21246116)

  • 21. FHL1 and Smad4 synergistically inhibit vascular endothelial growth factor expression.
    Zhou Z; Lu J; Dou J; Lv Z; Qin X; Lin J
    Mol Med Rep; 2013 Feb; 7(2):649-53. PubMed ID: 23184087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscle death participates in myofibrillar abnormalities in FHL1 knockout mice.
    Ding J; Cong Y; Li F; Liu B; Wu D; Miao J; Wang L
    Biochem Biophys Res Commun; 2020 Feb; 523(1):105-111. PubMed ID: 31836140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.
    Albrecht I; Wick C; Hallgren Å; Tjärnlund A; Nagaraju K; Andrade F; Thompson K; Coley W; Phadke A; Diaz-Gallo LM; Bottai M; Nennesmo I; Chemin K; Herrath J; Johansson K; Wikberg A; Ytterberg AJ; Zubarev RA; Danielsson O; Krystufkova O; Vencovsky J; Landegren N; Wahren-Herlenius M; Padyukov L; Kämpe O; Lundberg IE
    J Clin Invest; 2015 Dec; 125(12):4612-24. PubMed ID: 26551678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of recombinant and natural forms of the human LIM domain-containing protein FHL2.
    El Mourabit H; Müller S; Tunggal L; Paulsson M; Aumailley M
    Protein Expr Purif; 2003 Nov; 32(1):95-103. PubMed ID: 14680945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel FHL1 mutation in a family with reducing body myopathy.
    Schreckenbach T; Henn W; Kress W; Roos A; Maschke M; Feiden W; Dillmann U; Schulz JB; Weis J; Claeys KG
    Muscle Nerve; 2013 Jan; 47(1):127-34. PubMed ID: 23169582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four-and-a-half LIM Domains 1 (FHL1) Protein Interacts with the Rho Guanine Nucleotide Exchange Factor PLEKHG2/FLJ00018 and Regulates Cell Morphogenesis.
    Sato K; Kimura M; Sugiyama K; Nishikawa M; Okano Y; Nagaoka H; Nagase T; Kitade Y; Ueda H
    J Biol Chem; 2016 Nov; 291(48):25227-25238. PubMed ID: 27765816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy.
    Schessl J; Zou Y; McGrath MJ; Cowling BS; Maiti B; Chin SS; Sewry C; Battini R; Hu Y; Cottle DL; Rosenblatt M; Spruce L; Ganguly A; Kirschner J; Judkins AR; Golden JA; Goebel HH; Muntoni F; Flanigan KM; Mitchell CA; Bönnemann CG
    J Clin Invest; 2008 Mar; 118(3):904-12. PubMed ID: 18274675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Src-mediated phosphorylation converts FHL1 from tumor suppressor to tumor promoter.
    Wang X; Wei X; Yuan Y; Sun Q; Zhan J; Zhang J; Tang Y; Li F; Ding L; Ye Q; Zhang H
    J Cell Biol; 2018 Apr; 217(4):1335-1351. PubMed ID: 29434030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The novel roles of four and a half LIM proteins 1 and 2 in the cardiovascular system.
    Chu PH; Chen J
    Chang Gung Med J; 2011; 34(2):127-34. PubMed ID: 21539754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein trafficking and anchoring complexes revealed by proteomic analysis of inward rectifier potassium channel (Kir2.x)-associated proteins.
    Leonoudakis D; Conti LR; Anderson S; Radeke CM; McGuire LM; Adams ME; Froehner SC; Yates JR; Vandenberg CA
    J Biol Chem; 2004 May; 279(21):22331-46. PubMed ID: 15024025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
    D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
    Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the STAT3 interactome using in-situ biotinylation and SILAC.
    Blumert C; Kalkhof S; Brocke-Heidrich K; Kohajda T; von Bergen M; Horn F
    J Proteomics; 2013 Dec; 94():370-86. PubMed ID: 24013128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PDLIM1 inhibits NF-κB-mediated inflammatory signaling by sequestering the p65 subunit of NF-κB in the cytoplasm.
    Ono R; Kaisho T; Tanaka T
    Sci Rep; 2015 Dec; 5():18327. PubMed ID: 26679095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific activation of PLEKHG2-induced serum response element-dependent gene transcription by four-and-a-half LIM domains (FHL) 1, but not FHL2 or FHL3.
    Nishikawa M; Sato K; Nakano S; Yamakawa H; Nagase T; Ueda H
    Small GTPases; 2019 Sep; 10(5):361-366. PubMed ID: 28489964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rigid spine syndrome caused by a novel mutation in four-and-a-half LIM domain 1 gene (FHL1).
    Shalaby S; Hayashi YK; Goto K; Ogawa M; Nonaka I; Noguchi S; Nishino I
    Neuromuscul Disord; 2008 Dec; 18(12):959-61. PubMed ID: 18952429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FHL1 inhibits the growth of tongue squamous cell carcinoma cells via G1/S cell cycle arrest.
    Ren W; Lian P; Cheng L; Du P; Guan X; Wang H; Ding L; Gao Z; Huang X; Xiao F; Wang L; Bi X; Ye Q; Wang E
    Mol Med Rep; 2015 Sep; 12(3):3958-3964. PubMed ID: 26017856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FHL1 promotes glioblastoma aggressiveness through regulating EGFR expression.
    Sun L; Chen L; Zhu H; Li Y; Chen CC; Li M
    FEBS Lett; 2021 Jan; 595(1):85-98. PubMed ID: 33053208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy.
    Friedrich FW; Wilding BR; Reischmann S; Crocini C; Lang P; Charron P; Müller OJ; McGrath MJ; Vollert I; Hansen A; Linke WA; Hengstenberg C; Bonne G; Morner S; Wichter T; Madeira H; Arbustini E; Eschenhagen T; Mitchell CA; Isnard R; Carrier L
    Hum Mol Genet; 2012 Jul; 21(14):3237-54. PubMed ID: 22523091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rare variant in the FHL1 gene associated with X-linked recessive hypoparathyroidism.
    Pillar N; Pleniceanu O; Fang M; Ziv L; Lahav E; Botchan S; Cheng L; Dekel B; Shomron N
    Hum Genet; 2017 Jul; 136(7):835-845. PubMed ID: 28444561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of epigenetic inactivation of the human four and a half LIM domains 1 gene in human oral cancer.
    Koike K; Kasamatsu A; Iyoda M; Saito Y; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Tanzawa H; Uzawa K
    Int J Oncol; 2013 Jan; 42(1):141-50. PubMed ID: 23123766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.